Pembrolizumab, 5 mg
Order number: 1374853-91-4
Part number: AC100058374
£ 1030.99*
*Prices without VAT and shipping costs£ 1237.19*
*incl. VAT, plus shipping costsPrice Breakdown
This medication works by blocking the PD-1 receptor, allowing the immune system to target cancer cells more effectively. With its precise formulation, Pembrolizumab, 5 Mg provides a reliable option for medical professionals and researchers.
Core Characteristics of the Pembrolizumab, 5 Mg
- Packaged in convenient quantities to meet the needs of healthcare providers and research institutions.
- Suitable for use in oncology practices, where targeted therapies are crucial for patient care.
- Ideal for incorporation into combination regimens with other cancer treatments, enhancing overall treatment outcomes.
- Demonstrates remarkable stability when stored at controlled temperatures, maintaining its integrity during transportation and storage.
- Available in a sterile, single-use format, minimizing the risk of contamination and ensuring safe handling.
Formulation Overview
Pembrolizumab, 5 Mg is typically administered intravenously, allowing for efficient delivery of the active ingredient directly to the site of action.
Common Application Settings
- Maintenance cycles that include Pembrolizumab in the supply list.
- A to Z tasks that call for Pembrolizumab by name and pack size.
- Sites where Pembrolizumab matches the listed A to Z category.
- Operations planning around the container format shown for Pembrolizumab.
No attributes available
